Wes Wilson | Cancer Researcher and Tumor Immunologist

Dr. Wes Wilson
                             Dr. Wes Wilson

Wes is a Tumor Immunologist and Cancer Researcher at the University of Pennsylvania. He is cross appointed with Dr. Steven Albelda in Pulmonary Oncology and Dr. Mike Milone in Experimental Pathology.  Wes has been working in cancer research for over a decade with his focuses on developing new therapies for hard to treat diseases like childhood brain tumours, adult mesothelioma, and most recently at UPenn multiple myeloma. His specialties include focusing on modulation of the immune response to cancer using a variety of tools and technologies to characterize the cancer immune response and then leverage cutting edge immunotherapies such as checkpoint blockade immunotherapy and CAR-T cell therapy to continue to deliver improved responses for patients. 

 

 

 

 

 

 

 

In 2020/2021 Wes won the Young Investigators Award from the International Mesothelioma Interest Group for his work understanding the impacts of combination checkpoint blockade immunotherapy and radiotherapy. In this video Wes describes his the work that spanned 4 years that sets the ground work for new treatment protocols for Mesothelioma.
Wes is also active in the cancer support and broader cancer community previously working the Canadian Cancer Society, and more recently American Cancer Society. In 2020 & 2021 he also helped host Livestream for the Cure to raise $15,000 for cancer research. Keep an eye on this space on how you can participate in 2022!

Livestream for the Cure

Want to learn about the exciting advancements in cancer care that have sprung out from amazing cancer research? Here how immunotherapy works and how its changing the landscape of cancer therapy? Then check out Wes' 2018 TEDxTalk to learn how research really does make a difference!

 

Conference Presentation

Wes' Current Students:
Maximilian Greil (Post-grad)
Tej Patel (Undergrad)
Tarkh Fenix (Summer Student)